Extramedullary Plasmacytoma of the Breast as Initial Presentation of Multiple Myeloma: A Rare Case

Natalia Correa (1), Maya Kumar (2), Lynell Martinez (3), Christopher Montoya (4), Ashli Alexander (5), Simon Blanc (6), Jessica Burgers (7)
(1) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States,
(2) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States,
(3) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States,
(4) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States,
(5) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States,
(6) Holy Cross Medical Group – Michael & Dianne Bienes Comprehensive Cancer Center Hematology Oncology, Fort Lauderdale, Florida, United States,
(7) University of Miami Holy Cross Health General Surgery Resident Program, Fort Lauderdale, Florida, United States

Abstract

Background: Extramedullary involvement by systemic multiple myeloma is a rare manifestation of plasma cell myeloma, most commonly arising in the upper aerodigestive tract. Breast involvement is exceptionally uncommon and can mimic primary or recurrent breast carcinoma, creating diagnostic challenges.


Case Presentation: A 64-year-old woman with a history of invasive ductal carcinoma presented with a new breast lesion on screening mammography. Imaging demonstrated a small, circumscribed nodule, and core biopsy revealed monoclonal plasma cell infiltration. MRI showed multiple breast lesions, while bone marrow biopsy confirmed >90% plasma cell involvement with high-risk cytogenetics, including 1q21 amplification. These findings established a diagnosis of extramedullary involvement of the breast by systemic multiple myeloma (MM). The patient was treated with daratumumab-based systemic therapy, achieving remission with eventual minimal residual disease negativity on follow-up testing. She remains without clinical or radiographic evidence of breast disease.


Conclusion: Breast involvement by systemic MM is a rare manifestation of plasma cell myeloma and should be considered in the differential diagnosis of new breast lesions. Early biopsy and comprehensive pathologic evaluation are essential to avoid misdiagnosis and guide appropriate systemic therapy.

References

Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management. Am J Hematol. 2018;93(8):1091-1110. doi:10.1002/ajh.25117

Luh SP, Lai YS, Tsai CH, Tsao TCY. Extramedullary plasmacytoma (EMP): Report of a case manifested as a mediastinal mass and multiple pulmonary nodules and review of literature. World J Surg Oncol. 2007;5(1):123. doi:10.1186/1477-7819-5-123

Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85(11):2305-2314.

Le DK, Metter D, Krause JR. Plasmablastic Plasmacytoma of the Breast. Baylor University Medical Center Proceedings. 2017;30(2):203-204. doi:10.1080/08998280.2017.11929587

Ho M, Paruzzo L, Minehart J, et al. Extramedullary Multiple Myeloma: Challenges and Opportunities. Current Oncology. 2025;32(3):182. doi:10.3390/curroncol32030182

Hillengass J, Usmani S, Rajkumar SV, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20(6):e302-e312. doi:10.1016/S1470-2045(19)30309-2

Park YM. Imaging Findings of Plasmacytoma of Both Breasts as a Preceding Manifestation of Multiple Myeloma. Case Rep Med. 2016;2016:6595610. doi:10.1155/2016/6595610

Fischer TR da C, Higashi F, Crusoe E de Q, Hungria VT de M. Bilateral breast plasmacytoma: a clinical case report. Rev Bras Hematol Hemoter. 2016;38(2):166-169. doi:10.1016/j.bjhh.2016.03.003

Urano M, Denewar FA, Okabe R, et al. Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings. Radiol Case Rep. 2019;14(5):584-587. doi:10.1016/j.radcr.2019.02.018

Beydoun AS, Ovalle F, Brannock K, Gobble RM. A Case Report of a Breast Implant–Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant–Associated Neoplasms. Aesthet Surg J. 2019;39(7):NP234-NP239. doi:10.1093/asj/sjy315

Vong S, Navarro SM, Darrow M, Aminololama-Shakeri S. Extramedullary Plasmacytoma of the breast in a patient with Multiple Myeloma. J Radiol Case Rep. 2020;14(12):14-23. doi:10.3941/jrcr.v14i12.4110

Eden JK, Borgen R, Haq R, Dobrashian R. A rare imaging case of bilateral plasmacytoma of the breast. BJR Case Rep. 2020;6(2):20190131. doi:10.1259/bjrcr.20190131

Mehta M, Shah A, Shah I, Shah R, Suryanarayan U. Solitary Plasmacytoma of the Breast. Journal of Radiation and Cancer Research. 2021;12(1):33-35. doi:10.4103/jrcr.jrcr_14_20

Tawel H, Hasen Y, Arrgebe H, et al. Breast Plasmacytoma as Extra-Medullary Lesion of Multiple Myeloma: A Case Report. J Investig Med High Impact Case Rep. 2022;10:23247096221111772. doi:10.1177/23247096221111773

Mo CK, Lai AY, Lo SS, Wong T, Wong WW. Bilateral breast multiple myeloma: a case report. Hong Kong Medical Journal. 2022;28(6):488-490. doi:10.12809/hkmj219555

McCormack S, Hamad E, Hamad A. Solitary Plasmacytoma of the Breast: A Case of an Uncommon Breast Neoplasm. Case Rep Hematol. 2023;2023:1-5. doi:10.1155/2023/9622042

Shiva S, Gaurav K, Anand A, Raghuvanshi S, Sonkar AA. Solitary Plasmacytoma of the Breast: A Rare Entity. Cureus. 2024;16(2):e53612. doi:10.7759/cureus.53612

Madan NK, Malik S, Ahuja S. Isolated plasmacytoma of the breast: A rare case report. Int J Surg Case Rep. 2024;125(C). doi:10.1016/j.ijscr.2024.110654

Alsaleh B, Alanzi A, Alsaeed M, Farahat A, Alsaleh M, Mohamed H. Bilateral Breast Involvement in Multiple Myeloma: A Report of a Rare Case. Cureus. 2024;16(10):e70906. doi:10.7759/cureus.70906

Venkataraman P, Mehra N, Sundersingh S, Iyer P. Extramedullary Disease of the Breast in Multiple Myeloma—An Uncommon Initial Presentation: A Case Report and Review of Literature. Indian Journal of Medical and Paediatric Oncology. Published online January 17, 2025. doi:10.1055/s-0044-1801769

Silva MJ, Patel J, Huang A, Lo Gullo R, Pinker-Domenig K. Breast Plasmacytoma as the Initial Manifestation of Multiple Myeloma in a 36-Year-Old Woman. Cureus. 2025;17(7):e87929. doi:10.7759/cureus.87929

LIU Y, HE Z, WANG M, LANG J, ZHOU Y, WANG C. Multiple Myeloma Concurrent with Extramedullary Plasmacytoma of the Breast: A Case Report and Literature Review. Medical Journal of Peking Union Medical College Hospital . 2025;16(4):1002-1007.

Messina G, Fucile MA, Kupper M, et al. Multiple Myeloma Presenting as Breast Metastasis: Diagnostic Challenges and Case Analysis. American Journal of Case Reports. 2025;26. doi:10.12659/AJCR.945853

Eņģele I, Zablocka T, Asere E, Eglītis J. Bilateral breast plasmacytomas in a male patient with relapsed multiple myeloma: A case report. Radiol Case Rep. 2026;21(3):1231-1235. doi:10.1016/j.radcr.2025.11.054

Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229-1253. doi:10.1182/blood.2022015851

Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-1748. doi:10.1038/s41375-022-01620-2

Gregory C, Parks R, Srajagopal N, Gutteridge E. A rare case of extramedullary plasmacytoma in the breast – an incidental finding in a 100-year-old following a fall. The Annals of The Royal College of Surgeons of England. Published online October 1, 2025. doi:10.1308/rcsann.2025.0068

Dass J, Arava S, Mishra PC, Dinda AK, Pati HP. Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study. South Asian J Cancer. 2019;8(1):60-64. doi:10.4103/sajc.sajc_64_17

Bal S, Kumar SK, Fonseca R, et al. Multiple myeloma with t(11;14): unique biology and evolving landscape. Am J Cancer Res. 2022;12(7):2950-2965.

Padhi S, G’Boy Varghese R, Ramdas A. Cyclin D1 expression in multiple myeloma by immunohistochemistry: Case series of 14 patients and literature review. Indian Journal of Medical and Paediatric Oncology. 2013;34(04):283-291. doi:10.4103/0971-5851.125246

Zhao J, Cui Y, Fang B. Therapeutic options for extramedullary involvement in multiple myeloma. Clin Exp Med. 2025;25(1):301. doi:10.1007/s10238-025-01821-w

Bisht K, Walker B, Kumar SK, et al. Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies. Expert Rev Hematol. 2021;14(12):1099-1114. doi:10.1080/17474086.2021.1983427

Perrot A, Lauwers-Cances V, Tournay E, et al. Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma. Journal of Clinical Oncology. 2019;37(19):1657-1665. doi:10.1200/JCO.18.00776

Ho M, Paruzzo L, Minehart J, et al. Extramedullary Multiple Myeloma: Challenges and Opportunities. Current Oncology. 2025;32(3):182. doi:10.3390/curroncol32030182

Terpos E, Morgan G, Dimopoulos MA, et al. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease. Journal of Clinical Oncology. 2013;31(18):2347-2357. doi:10.1200/JCO.2012.47.7901

Authors

Natalia Correa
nc13gcorrea@gmail.com (Primary Contact)
Maya Kumar
Lynell Martinez
Christopher Montoya
Ashli Alexander
Simon Blanc
Jessica Burgers
1.
Correa N, Kumar M, Martinez L, Montoya C, Alexander A, Blanc S, Burgers J. Extramedullary Plasmacytoma of the Breast as Initial Presentation of Multiple Myeloma: A Rare Case. Arch Breast Cancer [Internet]. [cited 2026 Aug. 2];13(4). Available from: https://www.archbreastcancer.com/index.php/abc/article/view/1339

Article Details